Hemispherx Biopharma CEO Thomas Equels' 2018 pay rises 19% to $1.2M

Hemispherx Biopharma reports 2018 executive compensation

By ExecPay News

Published: August 20, 2019

Hemispherx Biopharma reported fiscal year 2018 executive compensation information on August 20, 2019.
In 2018, three executives at Hemispherx Biopharma received on average a compensation package of $697K, a 24% increase compared to previous year.
Average pay of disclosed executives at Hemispherx Biopharma
Thomas K. Equels, Chief Executive Officer, received $1.2M in total, which increased by 19% compared to 2017. 64% of Equels' compensation, or $751K, was in salary. Equels also received $18K in bonus, $336K in option awards, $500 in stock awards, as well as $66K in other compensation.
Peter Rodino, General Counsel, received a compensation package of $527K, which increased by 32% compared to previous year. 67% of the compensation package, or $351K, was in salary.
Adam Pascale, Chief Financial Officer, earned $392K in 2018, a 33% increase compared to previous year.

Related executives

Thomas Equels

Hemispherx Biopharma

Chief Executive Officer

Adam Pascale

Hemispherx Biopharma

Chief Financial Officer

Peter Rodino

Hemispherx Biopharma

General Counsel

You may also like

Source: SEC filing on August 20, 2019.